+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ipsen Group - logo

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

From
Osteoporosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 375 Pages
From
From
From
Brain Hemorrhage - Pipeline Insight, 2020 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
From
Pheochromocytoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Pheochromocytoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 161 Pages
From
Biliary Tract Cancer - Pipeline Insight, 2021 - Product Thumbnail Image

Biliary Tract Cancer - Pipeline Insight, 2021

  • Clinical Trials
  • July 2021
  • 60 Pages
From
AXL kinase inhibitors - Pipeline Insights, 2022 - Product Thumbnail Image

AXL kinase inhibitors - Pipeline Insights, 2022

  • Drug Pipelines
  • March 2022
  • 60 Pages
From
From
Sustained Release Injectables - Product Thumbnail Image

Sustained Release Injectables

  • Report
  • August 2021
  • 185 Pages
From
From
Ovarian Cancer (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Ovarian Cancer (Oncology) - Drugs in Development, 2021

  • Report
  • December 2021
  • 5066 Pages
From
Loading Indicator